Idt Australia logo

Idt Australia(ASX) IDT

Market CapA$16.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-50%
5 Year-94%
1 Year-37%
1 Month-19%
A$0.04
+2.70%
+0.00Today
Idt Australia last closing stock price
MetricPriceDate
Last closeAUD 0.042026-10-09
Idt Australia stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.32%AUD 0.042026-10-02
1 month-19.15%AUD 0.052026-09-09
3 month+18.75%AUD 0.032026-07-10
Year to date-25.49%AUD 0.052025-12-30
1 year-36.67%AUD 0.062025-10-09
3 year-35.59%AUD 0.062023-10-10
5 year-93.97%AUD 0.632021-10-08
Since inception-50.17%AUD 0.081992-01-02

Idt Australia Financials at a Glance

Market Cap

A$16.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$40.12M

Net Income (TTM)

-A$10.78M

EPS (TTM)

-A$0.01

P/E Ratio

-5.94

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$0.04

Volume

220,315

Open

A$0.04

Previous Close

A$0.04

Daily Range

A$0.04 - A$0.04

52-Week Range

A$0.03 - A$0.07

Estimated Earnings Date

Feb 23, 2027

IDT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Idt Australia

IDT Australia Limited is a pharmaceutical company engaged in the complete lifecycle of drug development, from research and development to manufacturing and distribution. The company specializes in both active pharmaceutical ingredients (APIs) and finished dosage forms, offering a range of services to support pharmaceutical development.

Products and Services
  • Manufacturing of active pharmaceutical ingredients and finished dosage forms
  • Comprehensive analytical support and quality control laboratory services
  • Contract manufacturing solutions, including medicinal cannabis products
Growth Outlook
  • Recent quarterly revenue reached AUD 10.63 million, showing a positive trend
  • Strong demand for contract manufacturing services is expected to drive growth
  • Expansion into medicinal cannabis products presents new market opportunities
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 36.5 million indicates steady performance
  • Current ratio of 2.33 suggests strong liquidity position
  • Net income for the latest quarter was AUD -1.4 million, reflecting ongoing investment in growth
IDT Australia Limited operates in the healthcare sector, focusing on drug manufacturing, including specialty and generic drugs. The company has established a solid foundation since its inception in 1975, with a headquarters in Boronia, Australia. The recent quarterly performance indicates a revenue increase, which is a positive sign for potential investors. The company's diverse offerings, including contract manufacturing and analytical services, position it well for future growth, particularly in the expanding medicinal cannabis market. The financial metrics, such as a strong current ratio, highlight the company's ability to meet short-term obligations, while the ongoing investments reflect a commitment to long-term growth strategies.
AI Generated • Sep 23, 2026

Industry

Pharmaceuticals

CEO

Mark Anthony Simari

Headquarters

Boronia, VIC 3155, AU

IDT Financials

Key Financial Metrics (TTM)

Gross Margin

21.10%

Operating Margin

-8.09%

Net Income Margin

-13.35%

Return on Equity

-13.81%

Return on Capital

-5.51%

Return on Assets

-7.79%

Earnings Yield

-16.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$16.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

428.28M

Volume

220.31K

Avg. Volume

182.88K

Financials (TTM)

Gross Profit

A$13.99M

Operating Income

-A$7.96M

EBITDA

-A$7.28M

Operating Cash Flow

-A$5.18M

Capital Expenditure

-A$2.61M

Free Cash Flow

-A$7.80M

Cash & ST Invst.

A$2.52M

Total Debt

A$10.83M

Idt Australia Performance Analysis

Idt Australia annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 6,935,000-42.7%
20242024-06-30AUD 13,226,00090.7%
20252025-06-30AUD 19,217,00045.3%
20262026-06-30AUD 20,357,0005.9%
Idt Australia sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3126.5%
Q42025-06-30-11.5%
Q22025-12-314.8%
Q42026-06-309.4%
Idt Australia annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.03621.3%
20242024-06-30AUD -0.02-54.3%
20252025-06-30AUD -0.0221.9%
20262026-06-30AUD -0.01-64.6%
Idt Australia sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-72.7%
Q42025-06-30-48.7%
Q22025-12-3172.6%
Q42026-06-30-6.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$10.63M

+28.3%

Gross Profit

A$1.96M

-61.4%

Gross Margin

18.45%

N/A

Market Cap

A$16.27MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$104.32K

N/A

Employees

156

N/A

Net Income

-A$1.40M

+9.9%

EBITDA

-A$300.00K

+80.7%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$2.52M

+178.2%

Total Debt

A$10.83M

+142.3%

Accounts Receivable

A$6.17M

-6.1%

Inventory

A$2.63M

+56.4%

Long Term Debt

A$10.09M

N/A

Short Term Debt

A$738.00K

-83.5%

Return on Assets

-7.79%

N/A

Return on Invested Capital

-5.61%

N/A

Free Cash Flow

-A$919.00K

+84.3%

Operating Cash Flow

-A$569.00K

+89.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AT1.AXAtomo Diagnostics Limited
A$0.02+0.00%
AGH.AXAlthea Group Holdings Limited
A$0.02-4.76%
NOX.AXNoxopharm Limited
A$0.06-1.61%
IMC.AXImmuron Limited
A$0.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$22.18-9.81%
WFFWf
$12.29+499.51%
VZVerizon Communications
$41.65-8.75%
SPCXSpace Exploration Technologies
$162.57+1.25%

Questions About IDT

What is the current price of Idt Australia?

Idt Australia is trading at A$0.04 per share.

What is the 52-week range for Idt Australia?

Over the past 52 weeks, Idt Australia has traded between A$0.03 and A$0.07.

How much debt does Idt Australia have?

As of the most recent reporting period, Idt Australia reported total debt of A$10.83M.

How much cash does Idt Australia have on hand?

Idt Australia reported A$2.52M in cash and cash equivalents in its most recent financial results.

What is Idt Australia’s dividend yield?

Idt Australia does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.